ARCHIVES

DCE Reorganization Planned To Stem Departures, Stabilize

This article is from The Cancer Letter archive.

Vol. 21 No. 12 | March 24, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Markup adds $22 Mil. To NCI Budget; Roper formally Named NCI Deputy Director

September 22, 1989

FDA Policy: silicone Breast Implant Restrictions Stand, FDA Tells Petitioners

November 7, 1997

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009

Roswell Park Researchers Win $1.6M For Tobacco Studies.

June 20, 2003

ASCO Awards Contract For D.C. Office

January 5, 1990

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005